You are here

COVID-19

Why Does It Feel Like Medtech Is Living in a Bill Murray Movie?

Medical Devices and Diagnostics Industry

Wed, 10/13/21 - 10:58 am

J&J proposes sliding booster timelines as FDA questions lack of data for Delta, older adults before adcomm

Endpoints

Wed, 10/13/21 - 10:55 am

Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination

PM Live

Wed, 10/13/21 - 10:47 am

multiple sclerosis

New Evidence Suggests COVID-19 Vaccines Might Mitigate Long COVID

BioSpace

Tue, 10/12/21 - 12:05 pm

Pfizer-BioNTech Lead Globally with COVID-19 Vaccine

BioSpace

Tue, 10/12/21 - 11:50 am

Should Intuitive Surgical's Shareholders Worry About the Delta Variant?

Motley Fool

Tue, 10/12/21 - 11:09 am

Intuitive Surgical

robotic surgery

elective procedures

CureVac drops COVID-19 vaccine candidate; shifts focus to second-generation mRNA program

Biopharma Reporter

Tue, 10/12/21 - 11:06 am

Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it

Fortune

Tue, 10/12/21 - 11:02 am

viral resistance

Merck Reportedly Plans To Double Production Of New Covid-Fighting Pill As Wealthy Countries Corner Scarce Supplies

Forbes

Tue, 10/12/21 - 10:57 am

drug manufacturing

CDC sets panel meetings for J&J, Moderna boosters, child vaccines

The Hill

Mon, 10/11/21 - 09:59 pm

Moderna Therapeutics

GSK and Vir turn to US for distribution as Covid-19 mAb treatment nears blockbuster status

Endpoints

Mon, 10/11/21 - 09:50 pm

Vir Biotechnology

monoclonal antibodies

Merck asks FDA to authorize promising anti-COVID pill

NPR

Mon, 10/11/21 - 10:29 am

Ridgeback Therapeutics

AstraZeneca's COVID-19 therapy hits goal in phase 3, but efficacy falls short of rivals

Fierce Biotech

Mon, 10/11/21 - 10:15 am

clinical trials

Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late?

Motley Fool

Sun, 10/10/21 - 09:52 pm

clinical trials

Lumen lands another DoD contract to treat Covid-related GI issues

Endpoints

Sat, 10/9/21 - 11:01 pm

Lumen Biosciences

Department of Defense

monoclonal antibodies

Can This Duo Outperform Merck and Ridgeback Biotherapeutics' COVID Treatment?

Motley Fool

Fri, 10/8/21 - 10:58 am

Ridgeback Therapeutics

Atea Pharmaceuticals

CDC director defends decision to overrule expert panel on Covid booster shots for health and other frontline workers

Stat

Thu, 10/7/21 - 09:45 pm

Rochelle Walensky

Women's COVID-19 antibody levels top men's after 2nd Pfizer shot, study finds

Beckers Hospital Review

Thu, 10/7/21 - 09:41 pm

A Breakthrough COVID-19 Diagnostic Faces Recall

Medical Devices and Diagnostics Industry

Thu, 10/7/21 - 09:37 pm

product recalls

Pfizer, BioNTech ask FDA to authorize Covid-19 vaccine for kids 5-11

Politico

Thu, 10/7/21 - 09:36 pm

Pages